KalVista Pharmaceuticals, Inc. (KALV)

NASDAQ: KALV · IEX Real-Time Price · USD

11.51

-0.38 (-3.20%)

At close: Jul 2, 2024, 4:00 PM

11.55

+0.04 (0.35%)

After-hours: Jul 2, 2024, 5:06 PM EDT

KalVista Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is May - April.

Millions USD. Fiscal year is May - Apr.

Year	2023	2022	2021	2020	2019	2018 - 2012
Revenue	0	0	0	12.69	16.13	Upgrade
Revenue Growth (YoY)	-	-	-	-21.31%	92.13%	Upgrade
Gross Profit	0	0	0	12.69	16.13	Upgrade
Selling, General & Admin	30.6	26.45	16.64	13.03	10.93	Upgrade
Research & Development	80.28	70.17	41.29	40.19	35.02	Upgrade
Operating Expenses	110.87	96.61	57.92	53.22	45.95	Upgrade
Operating Income	-110.87	-96.61	-57.92	-40.53	-29.82	Upgrade
Other Expense / Income	-17.96	-14.27	-11.68	-11.29	-9.13	Upgrade
Pretax Income	-92.91	-82.34	-46.24	-29.24	-20.69	Upgrade
Income Tax	0	0	0	-0.12	0.12	Upgrade
Net Income	-92.91	-82.34	-46.24	-29.12	-20.82	Upgrade
Shares Outstanding (Basic)	28	24	19	18	15	Upgrade
Shares Outstanding (Diluted)	28	24	19	18	15	Upgrade
Shares Change	13.97%	28.17%	7.58%	17.69%	46.11%	Upgrade
EPS (Basic)	-3.33	-3.36	-2.42	-1.64	-1.38	Upgrade
EPS (Diluted)	-3.33	-3.36	-2.42	-1.64	-1.38	Upgrade
Free Cash Flow	-76.46	-79.07	-30.25	-45.04	-37.45	Upgrade
Free Cash Flow Per Share	-2.74	-3.23	-1.58	-2.54	-2.48	Upgrade
Gross Margin	-	-	-	100.00%	100.00%	Upgrade
Operating Margin	-	-	-	-319.41%	-184.91%	Upgrade
Profit Margin	-	-	-	-229.44%	-129.08%	Upgrade
Free Cash Flow Margin	-	-	-	-354.89%	-232.19%	Upgrade
EBITDA	-92.11	-81.6	-45.59	-28.72	-20.31	Upgrade
EBITDA Margin	-	-	-	-226.28%	-125.96%	Upgrade
Depreciation & Amortization	0.8	0.74	0.65	0.53	0.38	Upgrade
EBIT	-92.91	-82.34	-46.24	-29.24	-20.69	Upgrade
EBIT Margin	-	-	-	-230.42%	-128.31%	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).